LGALS2 Human

Galectin-2 Human Recombinant
Cat. No.
BT10463
Source
Escherichia Coli.
Synonyms
HL14, Gal-2, Beta-galactoside-binding lectin L-14-II, Lactose-binding lectin 2, S-Lac lectin 2.
Appearance
Sterile Filtered colorless solution.
Purity
Greater than 95.0% as determined by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

LGALS2 Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 152 amino acids (1-132 a.a.) and having a molecular mass of 16.8 kDa. The LGALS2 is fused to a 20 amino acid His-Tag at N-terminus and purified by proprietary chromatographic techniques.

Product Specs

Introduction
LGALS2, a soluble beta-galactoside binding lectin, regulates cell-to-cell and cell-to-extracellular matrix interactions. It plays a role in tumor development, pre-mRNA splicing, and apoptosis. LGALS2 can trigger apoptosis in activated T cells and binds to lymphotoxin-alpha (LTA), potentially increasing the risk of myocardial infarction.
Description
Recombinant Human LGALS2, expressed in E. coli, is a non-glycosylated polypeptide chain with 152 amino acids (1-132 a.a.) and a molecular weight of 16.8 kDa. A 20 amino acid His-Tag is fused to the N-terminus. Purification is achieved using proprietary chromatographic methods.
Physical Appearance
A sterile, colorless solution.
Formulation
The Galectin-2 His tag protein solution is provided at a concentration of 0.5mg/ml and contains 20mM Tris-HCl (pH 8), 0.2M NaCl, 10% glycerol, and 1mM DTT.
Stability
For short-term storage (2-4 weeks), keep at 4°C. For extended storage, freeze at -20°C. Adding a carrier protein (0.1% HSA or BSA) is recommended for long-term storage. Avoid repeated freeze-thaw cycles.
Purity
Purity exceeds 95.0%, as assessed by SDS-PAGE.
Synonyms
HL14, Gal-2, Beta-galactoside-binding lectin L-14-II, Lactose-binding lectin 2, S-Lac lectin 2.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MTGELEVKNM DMKPGSTLKI TGSIADGTDG FVINLGQGTD KLNLHFNPRF SESTIVCNSL DGSNWGQEQR
EDHLCFSPGS EVKFTVTFES DKFKVKLPDG HELTFPNRLG HSHLSYLSVR GGFNMSSFKL KE.

Product Science Overview

Introduction

Galectin-2 is a member of the galectin family, which consists of carbohydrate-binding proteins with a high affinity for β-galactosides. These proteins play crucial roles in various biological processes, including cell-cell adhesion, cell-matrix interactions, and immune responses. Galectin-2, in particular, has garnered interest due to its unique properties and potential therapeutic applications.

Structure and Expression

Galectin-2 is a homodimeric protein with a molecular weight of approximately 14 kDa . It shares structural similarities with galectin-1 but has a distinct expression profile. Unlike galectin-1, which is widely expressed in various tissues, galectin-2 is primarily confined to the gastrointestinal tract . This restricted expression pattern suggests specialized functions in this region.

Gene and Protein Characteristics

The gene encoding galectin-2 is located on chromosome 22 in humans. The protein consists of a single carbohydrate recognition domain (CRD), which is responsible for its binding to β-galactosides . The amino acid sequence of human galectin-2 shares significant identity with its mouse and rat counterparts, indicating a conserved function across species .

Biological Functions

Galectin-2 has been shown to play a role in various biological processes:

  1. Cell Adhesion and Migration: Galectin-2 can enhance the adhesion of human umbilical vein endothelial cells (HUVECs), suggesting a role in vascular biology .
  2. Immune Regulation: Galectin-2 induces apoptosis in activated T cells through a caspase-dependent pathway. This proapoptotic effect is mediated by the intrinsic apoptotic pathway, involving the release of cytochrome c and the regulation of Bax/Bcl-2 expression . This property positions galectin-2 as a potential therapeutic agent for modulating immune responses.
  3. Gastrointestinal Functions: Given its expression in the gastrointestinal tract, galectin-2 may be involved in maintaining gut homeostasis and modulating inflammatory responses in this region .
Recombinant Production

Recombinant human galectin-2 is typically produced using human embryonic kidney (HEK) 293 cells. The recombinant protein is purified to high levels of purity, often exceeding 95%, and is free from endotoxins . This high-quality recombinant protein is used in various research applications, including studies on cell adhesion, apoptosis, and immune regulation.

Therapeutic Potential

The unique properties of galectin-2, particularly its ability to induce apoptosis in activated T cells, make it a promising candidate for therapeutic applications. It could be explored as a treatment for autoimmune diseases, where the selective elimination of activated T cells is desirable. Additionally, its role in modulating immune responses opens avenues for its use in cancer immunotherapy and inflammatory diseases .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.